Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Accumulated Expenses (2022 - 2025)

Core Laboratories (CLB) has 4 years of Accumulated Expenses data on record, last reported at $23.4 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 4.86% year-over-year to $23.4 million; the TTM value through Sep 2025 reached $23.4 million, up 4.86%, while the annual FY2024 figure was $22.9 million, 21.87% up from the prior year.
  • Accumulated Expenses reached $23.4 million in Q3 2025 per CLB's latest filing, down from $25.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $25.3 million in Q2 2025 and bottomed at $18.8 million in Q4 2023.
  • Average Accumulated Expenses over 4 years is $22.1 million, with a median of $22.3 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: dropped 19.8% in 2023, then increased 21.87% in 2024.
  • A 4-year view of Accumulated Expenses shows it stood at $23.4 million in 2022, then decreased by 19.8% to $18.8 million in 2023, then grew by 21.87% to $22.9 million in 2024, then increased by 2.02% to $23.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $23.4 million in Q3 2025, $25.3 million in Q2 2025, and $24.0 million in Q1 2025.